Biogen Inc. (BIIB)
NASDAQ: BIIB · Real-Time Price · USD
133.60
-0.61 (-0.45%)
Jul 14, 2025, 3:40 PM - Market open

Biogen Market Cap

Biogen has a market cap or net worth of $19.58 billion as of July 14, 2025. Its market cap has decreased by -39.76% in one year.

Market Cap
19.58B
Enterprise Value
23.65B
1-Year Change
-39.76%
Ranking
Category
Stock Price
$133.60

Market Cap Chart

Since December 1, 1998, Biogen's market cap has increased from $617.50M to $19.58B, an increase of 3,070.22%. That is a compound annual growth rate of 13.86%.

History

DateMarket Cap% Change
Jul 11, 2025 19.67B -11.75%
Dec 31, 2024 22.28B -40.57%
Dec 29, 2023 37.50B -5.97%
Dec 30, 2022 39.88B 13.15%
Dec 31, 2021 35.24B -6.47%
Dec 31, 2020 37.68B -29.63%
Dec 31, 2019 53.54B -11.69%
Dec 31, 2018 60.63B -10.00%
Dec 29, 2017 67.37B 9.19%
Dec 30, 2016 61.70B -9.65%
Dec 31, 2015 68.29B -14.82%
Dec 31, 2014 80.16B 21.39%
Dec 31, 2013 66.04B 90.69%
Dec 31, 2012 34.63B 29.54%
Dec 30, 2011 26.73B 67.31%
Dec 31, 2010 15.98B 3.27%
Dec 31, 2009 15.47B 11.34%
Dec 31, 2008 13.90B -16.78%
Dec 31, 2007 16.70B 0.70%
Dec 29, 2006 16.58B 7.90%
Dec 30, 2005 15.37B -30.83%
Dec 31, 2004 22.22B 288.89%
Dec 31, 2003 5.71B 12.55%
Dec 31, 2002 5.08B -51.71%
Dec 31, 2001 10.51B 21.91%
View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 711.91B
Johnson & Johnson 377.51B
AbbVie 339.94B
Novo Nordisk 305.41B
UnitedHealth Group 275.86B
Novartis AG 236.71B
Abbott Laboratories 229.69B
AstraZeneca 218.74B
Market Cap Rankings